Speaker illustration

Ms Caroline Sindet-Pedersen

Gentofte Hospital - Copenhagen University Hospital, Hellerup (Denmark)

Risk of worsening heart failure and all-cause mortality following mRNA covid-19 vaccination in patients with heart failure: a Danish nationwide real-world safety study

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Covid-19 and heart failure

Thumbnail

Comparative safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism - a Danish nationwide study

Event: ESC Congress 2017

Topic: Acute pulmonary embolism

Session: What is new in venous thromboembolism?

Thumbnail

Increasing use of NOAC and antiplatelet combination therapy in atrial fibrillation following myocardial infarction or percutaneous coronary intervention

Event: ESC Congress 2017

Topic: Antiarrhythmic drugs

Session: Drug treatment in patients with arrhythmia

Thumbnail

Equal safety of rivaroxaban and vitamin K antagonists with regard to the risk of intracranial- and gastrointestinal bleeding in patients with venous thromboembolism - A Danish nationwide study

Event: ESC Congress 2016

Topic: Thrombosis and coagulation

Session: Antithrombotics in daily clinical practice

Thumbnail

Familial clustering of venous thromboembolism - A Danish nationwide cohort study

Event: ESC Congress 2016

Topic: Thrombosis and coagulation

Session: Insights on thrombosis and anticoagulants

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb